Get 40% Off
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list

Novavax Climbs Premarket; Tesla, Ulta Beauty Fall

Published 12/03/2021, 12:58
Updated 12/03/2021, 12:59
© Reuters.

By Peter Nurse 

Investing.com -- Stocks in focus in premarket trade on Friday, March 12th. Please refresh for updates.

  • Novavax (NASDAQ:NVAX) stock soared 16% after the drug maker said its Covid-19 vaccine was 96% effective in preventing cases caused by the original version of the coronavirus in a late-stage trial, moving it a step closer to regulatory approval. It also showed 86% efficacy against the new variant first observed in the U.K. and 60% efficacy against the so-called South African variant.

  • Tesla (NASDAQ:TSLA) stock fell 2.9% after a fire at the electric carmaker’s factory in Fremont, California. There were no reports of injuries, and the fire has been brought under control, but it could set back production at a time when rivals are also ramping up output..

  • DocuSign (NASDAQ:DOCU) stock fell 4% despite the company reporting better than expected fourth-quarter results and delivering upbeat guidance. The stock has gained around 200% over the last year.

  • Ulta Beauty (NASDAQ:ULTA) stock fell 9.1% after the beauty retailer announced that CEO Mary Dillon will be stepping down in June, to be replaced by  company president Dave Kimbell. Additionally, net sales fell 4.6% from the fourth quarter of 2019 partly due to pandemic lockdowns and a decrease in cosmetics sales. 

  • Funko (NASDAQ:FNKO) stock rose 10% after the toy manufacturer posted strong fourth-quarter results, helped by strong sales in key products lines like “The Mandalorian”.

  • Poshmark (NASDAQ:POSH) stock slumped 12% after the e-commerce company offered disappointed guidance for the current quarter in its first results since going public.

  • JD.com (NASDAQ:JD) ADR fell 3% after Reuters reported that the Chinese e-commerce company is in talks to buy part or all of a stake in brokerage Sinolink Securities worth at least $1.5 billion.

  • Translate Bio (NASDAQ:TBIO) stock rose 5% after the therapeutics company announced it has started, along with partner Sanofi (PA:SASY) (NASDAQ:SNY), a clinical trial for its Covid-19 vaccine candidate.

  • Alibaba (NYSE:BABA) ADR fell 2.1%, Baidu (NASDAQ:BIDU) stock fell 2.5% and Tencent (HK:0700) Music (NYSE:TME) stock fell 3% after a group of 12 companies were fined - albeit largely token amounts - by the Chinese regulator for anti-competitive practices. 

  • Netflix (NASDAQ:NFLX) stock fell 1.3%, weakening with the tech selloff, while the streaming service is testing a new policy aimed at stopping the sharing of subscriber passwords.

  • Verizon (NYSE:VZ) stock rose 0.5% after the telecommunications giant saw healthy demand at its $25 billion debt sale to help expand its next-generation 5G mobile service.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.